Krispy Kreme: The C...
Endologix Inc. (ELGX: NASDAQ)
$13.23 -0.36 | -2.65%
06/01/12 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 13.23 |
| 52 Week High | 15.29 |
| 52 Week Low | 7.25 |
| Avg. Daily Vol. (Mil) | 0.38 |
| Beta (3 year) | 1.23 |
| Share Related Items | |
| Mkt Cap (Mil) | 770.51 |
| Shares Out (Mil) | 58.24 |
| Float (Mil) | 56.11 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.20 |
| Current Ratio | 3.60 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 8.62 |
| Price/Book | 12.51 |
| Price/Cash Flow | -20.30 |
| Per Share Data | |
| Earnings | -0.72 |
| Sales | 1.53 |
| Book Value | 1.06 |
| Cash Flow | -0.65 |
| Business Summary | |
|---|---|
| Endologix, Inc. is engaged in the development, manufacturing, marketing and sale of innovative treatments for aortic disorders. Its main product is the Powerlink System for the treatment of AAA. | |
| General Information | |
| 11 Studebaker Road
Irvine, CA 92618 |
|
| www.radiance.net | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 370 | |
| CEO: John McDermott | |
| Short Interest | |
| Current Month (Mil) | 4.29 |
| Previous Month (Mil) | 4.21 |
| Short Interest Ratio (Days) | 12.70 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -31.60 |
| Return on Investments | -66.00 |
| Profitability | |
| Gross Margin | 80.90 |
| EBIT Margin | -44.90 |
| Profit Margin | -45.50 |
Portfolios with ELGX
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks At New 52-Week Highs...
- UserGetting in the Game
- ContributorBarron's Activist Stocks 7-...
- ContributorBarron's Activist Stocks 5-...
- Usernew but likeit
- ContributorBarron's Activist Stocks 6-...
- ContributorBarron's Activist Stocks 10...
- Userhealthcare and staples
Latest ELGX Headlines from TheStreet
- Endologix Stock Falls On Unusually High Volume (ELGX) 05.31.12 | 04:05 pm
- Endologix's CEO Presents At The 2012 Bank Of America Merrill Lynch Health Care Conference (Transcript) 05.16.12 | 09:05 pm
- Endologix's CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.26.12 | 10:04 pm
- 7 Stocks Rising on Huge Volume 03.14.12 | 02:03 pm
- 5 Stocks Poised for Breakouts 02.28.12 | 01:02 pm
- Endologix Inc. Stock Downgraded (ELGX) 02.27.12 | 04:02 am
- Endologix's CEO Discusses Q4 2011 Results - Earnings Call Transcript 02.22.12 | 07:02 pm
- Endologix Reaches New 52-Week High (ELGX) 02.03.12 | 09:02 am
- Endologix Stock Hits New 52-Week High (ELGX) 01.25.12 | 01:01 pm
- Endologix Stock Hits New 52-Week High (ELGX) 01.13.12 | 12:01 pm
Press Releases for ELGX
Partner Headlines for ELGX
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 12.21.11 | 09:12 am
- Short Ideas: 20 Small Cap Stocks With Rising Receivables - Seeking Alpha 02.04.11 | 04:02 am
- 9 High Growth Stocks With Improving Analyst Sentiment - Seeking Alpha 01.14.11 | 06:01 am
- Zacks #5 Rank Additions for Tuesday - Tale of the Tape - Zacks 11.02.10 | 09:11 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 09.22.10 | 09:09 am
- Endologix Disputes Alleged Patent Infringement - Benzinga 08.11.10 | 04:08 pm
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 04.26.10 | 08:04 am





